CRISPR Therapeutics AG (CRSP) Return on Assets [ROA] (2016 - 2026)
CRISPR Therapeutics AG's Return on Assets [ROA] was -16.78% in Q2 2026, up 5.52 percentage points from -22.30% a year earlier and up 6.00 percentage points from the prior quarter.
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) Return on Assets [ROA] (2016 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at CRISPR Therapeutics AG came in at -25.81%, down 9.43 percentage points from FY2024.
- Return on Assets [ROA] shows a five-year change of -1.70 percentage points (FY2020 to FY2025).
- In earlier years, Return on Assets [ROA] was -16.38% in FY2024 (-9.51 pp), -6.87% in FY2023 (+19.16 pp), -26.03% in FY2022 (-42.53 pp) and 16.49% in FY2021 (+40.60 pp).
- The Q2 2026 figure marks the highest quarterly Return on Assets [ROA] since Q4 2024.
- Compared with a year earlier, Return on Assets [ROA] was higher in two of the last eight quarters, with an average year-over-year change of -5.52 percentage points.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q4 2021 (a gain of 34.61 percentage points); the worst was Q2 2022 (a drop of 43.38 percentage points).
- Per Business Quant data, CRSP's Return on Assets [ROA] in the three quarters before Q2 2026 was -22.78% (Q1 2026), -25.79% (Q4 2025) and -22.84% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | CRISPR Therapeutics AG | 5.36 Bn | 5.36 Bn | - | -16.78% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -16.78% |
| Mar 31, 2026 | -22.78% |
| Dec 31, 2025 | -25.79% |
| Sep 30, 2025 | -22.84% |
| Jun 30, 2025 | -22.30% |
| Mar 31, 2025 | -17.50% |
| Dec 31, 2024 | -16.29% |
| Sep 30, 2024 | -10.43% |
| Jun 30, 2024 | -11.12% |
| Mar 31, 2024 | -9.30% |
| Dec 31, 2023 | -7.12% |
| Sep 30, 2023 | -16.50% |
| Jun 30, 2023 | -18.73% |
| Mar 31, 2023 | -23.35% |
| Dec 31, 2022 | -28.29% |
| Sep 30, 2022 | -28.27% |
| Jun 30, 2022 | -24.99% |
| Mar 31, 2022 | 11.63% |
| Dec 31, 2021 | 13.55% |
| Sep 30, 2021 | 14.40% |
API Access
CRISPR Therapeutics AG Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CRSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "CRSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CRSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();